SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/75336"
 

Search: id:"swepub:oai:gup.ub.gu.se/75336" > Raloxifene- and est...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice.

Erlandsson, M C (author)
Jonsson, C A (author)
Lindberg, Marie K, 1975 (author)
Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin,Institute of Internal Medicine
show more...
Ohlsson, Claes, 1965 (author)
Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin, Avdelningen för internmedicin,Institute of Internal Medicine, Dept of Medicine
Carlsten, Hans, 1954 (author)
Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin, Avdelningen för reumatologi och inflammationsforskning,Institute of Internal Medicine, Dept of Rheumatology and Inflammation Research
show less...
 (creator_code:org_t)
2002
2002
English.
In: The Journal of endocrinology. - 0022-0795. ; 175:2, s. 319-27
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Raloxifene is a selective estrogen receptor modulator approved for the prevention of osteoporosis in postmenopausal women. It is selective by having estrogen-agonistic effects on bone, vessels and blood lipids while it is antagonistic on mammary and uterine tissue. Our aim was to study the agonistic and antagonistic properties of the raloxifene analogue LY117018 (LY) on uterus, bone, B lymphopoiesis and B cell function. Oophorectomized and sham-operated animals were treated with s.c. injections of equipotent anti-osteoporotic doses of 17beta-estradiol (E2) (0.1 mg/kg) or LY (3 mg/kg) or vehicle as controls. Effects on bone mineral density (BMD) were studied using peripheral quantitative computed tomography, uterine weight was examined, B lymphopoiesis was examined using flow cytometry and B cell function in bone marrow and spleen was studied by the use of an ELISPOT assay. E2 and LY had similar effects on BMD and bone marrow B lymphopoiesis, while LY had a clear antagonistic effect on endogenous estrogen in uterine tissue and no stimulating effect on the frequency of Ig-producing B cells in sham-operated animals. Our results are discussed in the context of estrogen receptor biology, relations between the immune system and bone metabolism and also with respect to the estrogen-mediated effects on rheumatic diseases.

Keyword

Animals
B-Lymphocytes
drug effects
Bone and Bones
drug effects
Estradiol
pharmacology
Female
Flow Cytometry
Immunoenzyme Techniques
methods
Insulin-Like Growth Factor I
drug effects
Lymphopoiesis
drug effects
Mice
Mice
Inbred C57BL
Pyrrolidines
pharmacology
Selective Estrogen Receptor Modulators
pharmacology
Spleen
drug effects
Thiophenes
pharmacology
Tomography
X-Ray Computed
Uterus
drug effects

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view